These familial cases usually manifest as early onset AD and are commonly associated with genetic mutations in amyloid precursor protein (APP), presenilin 1 (PS1), and presenilin 2 (PS2) (Swerdlow, 2007; van der Flier et al., 2011). This evidence concerns the gene APP and Alzheimer disease.